Effectiveness of maximal safe resection for glioblastoma including elderly and low Karnofsky performance status patients: retrospective review at a single institute
- PMID: 22976140
- DOI: 10.2176/nmc.52.570
Effectiveness of maximal safe resection for glioblastoma including elderly and low Karnofsky performance status patients: retrospective review at a single institute
Abstract
Elderly and low Karnofsky performance status (KPS) patients have been excluded from most prospective trials. This retrospective study investigated glioblastoma treatment outcomes, including those of elderly and low KPS patients, and analyzed the prognostic factors using the medical records of 107 consecutive patients, 59 men and 48 women aged from 21 to 85 years (median 65 years), with newly diagnosed glioblastoma treated at our institute. There were 71 high-risk patients with age >70 years and/or KPS <70%. Based on the extent of resection, the patients were classified into 3 groups: more than subtotal resection (subtotal, n = 44), partial resection (partial, n = 29), and biopsy only (biopsy, n = 34). Median overall survival (OS) of all 107 patients was 13.5 months. Median OS was 13.2 months in the high-risk group. Median OSs were 15.8, 12.8, and 12.1 months in the subtotal, partial, and biopsy groups, respectively. Multivariate analysis of 73 patients in the subtotal and partial groups found age ≤65 years (p = 0.047), 60 Gy irradiation (p = 0.009), O(6)-methylguanine-deoxyribonucleic acid methyltransferase-negative (p = 0.027), and more than subtotal removal (p = 0.003) were significant prognostic factors. The median postoperative KPS score tended to be better than the preoperative score, even in the high-risk group. We recommend maximal safe resection for glioblastoma patients, even those with advanced age and/or with low KPS scores.
Similar articles
-
Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival.J Neurosurg. 2016 Apr;124(4):998-1007. doi: 10.3171/2015.4.JNS142200. Epub 2015 Oct 9. J Neurosurg. 2016. PMID: 26452121
-
Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.J Neurosurg. 2011 Aug;115(2):220-9. doi: 10.3171/2011.3.JNS10495. Epub 2011 May 6. J Neurosurg. 2011. PMID: 21548745
-
Treatment results and outcome in elderly patients with glioblastoma multiforme--a retrospective single institution analysis.Clin Neurol Neurosurg. 2015 Jan;128:60-9. doi: 10.1016/j.clineuro.2014.11.006. Epub 2014 Nov 15. Clin Neurol Neurosurg. 2015. PMID: 25462098
-
Assessing the efficacy of repeat resections in recurrent glioblastoma: a systematic review.Neurosurg Rev. 2021 Jun;44(3):1259-1271. doi: 10.1007/s10143-020-01331-1. Epub 2020 Jun 13. Neurosurg Rev. 2021. PMID: 32533385
-
Treatment outcome and prognostic factors of adult glioblastoma multiforme.J Egypt Natl Canc Inst. 2013 Mar;25(1):21-30. doi: 10.1016/j.jnci.2012.11.001. Epub 2012 Dec 21. J Egypt Natl Canc Inst. 2013. PMID: 23499203 Review.
Cited by
-
Carmustine wafer implantation for supratentorial glioblastomas, IDH-wildtype in "extreme" neurosurgical conditions.Neurosurg Rev. 2023 Jun 17;46(1):140. doi: 10.1007/s10143-023-02052-x. Neurosurg Rev. 2023. PMID: 37329341
-
The Impact of Perioperative Arterial Infarct on Recurrence, Functional Outcomes, and Survival in Glioblastoma Patients.Front Oncol. 2020 May 13;10:706. doi: 10.3389/fonc.2020.00706. eCollection 2020. Front Oncol. 2020. PMID: 32477945 Free PMC article.
-
Association of the Extent of Resection With Survival in Glioblastoma: A Systematic Review and Meta-analysis.JAMA Oncol. 2016 Nov 1;2(11):1460-1469. doi: 10.1001/jamaoncol.2016.1373. JAMA Oncol. 2016. PMID: 27310651 Free PMC article.
-
Surgical Complexity and Complications: The Need for a Common Language.Acta Neurochir Suppl. 2023;130:1-12. doi: 10.1007/978-3-030-12887-6_1. Acta Neurochir Suppl. 2023. PMID: 37548717
-
Prognostic value of tumour volume in patients with a poor Karnofsky performance status scale - a bicentric retrospective study.BMC Neurol. 2021 Nov 15;21(1):446. doi: 10.1186/s12883-021-02424-0. BMC Neurol. 2021. PMID: 34781889 Free PMC article.